statview 4.02 software program (Abacus Concepts)
90
Structured Review
Abacus Concepts
statview 4.02 software program
Statview 4.02 Software Program, supplied by Abacus Concepts, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/statview+4%2E02+software+program/statview/pm33862952-98-1-5
Average 90 stars, based on 1 article reviews
Statview 4.02 Software Program, supplied by Abacus Concepts, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/statview+4%2E02+software+program/statview/pm33862952-98-1-5
Average 90 stars, based on 1 article reviews
statview 4.02 software program - by Bioz Stars,
2026-11
90/100 stars
Images
Related Articles
Transfection:Article Title: Prophylaxis of osteoporosis with calcium, estrogens and/or eelcatonin: comparative longitudinal study of bone mass. Article Snippet: Objective: To evaluate three different therapeutic regimens for the prevention of osteoporosis in natural and surgical postmenopausal women who had been found to have rapid bone loss in analytical studies.. Methods: A total of 104 naturally or surgically postmenopausal women were studied, and subsequently followed-up during 1 year for avoidance of the influence of seasonal variation on bone mass, a factor overlooked in several studies.. They were randomized into four groups of 26 patients each: the untreated control group (mean age 50 + 5 years); the hormonal replacement treatment (HRT) group (mean age 48 + 6 years), which was treated for 24 days each month with transdermal 17/I-estradiol, 50 mg/day, together with medroxiprogesterone, 10 mg during 12 days; the calcium group (mean age 50 _+ 4 years), which was treated with elemental calcium, 1 g/day; and the calcitonin group (mean age 50 _+ 5 years), which was treated for 10 days each month with eel calcitonin, 40 IU/day and with elemental calcium, 500 mg/day. Article Title: Antisense galectin-3 alters thymidine incorporation in human MDA-MB435 breast cancer cells Article Snippet: Galectin-3 is a 30-kDa galactose-binding protein member of the galectin family.. Galectin-3 is involved in multiple intracellular and extracellular biological functions, e.g. interactions with laminin and with nucleic acids.. This latter property is consistent with the presence of a serumresponse factor-like domain at the amino-terminal part of the protein. Article Title: Evidence that the loss of bone mass induced by GnRH agonists is not totally recovered. Article Snippet: There is disagreement as to whether the loss of bone mass induced by GnRH agonists is reversible.. In part, the differences of opinion might be attributed to the fact that the influence of weight and seasonal changes on bone mass is often overlooked.. Taking into consideration weight and seasonal changes in bone mass, total (TBBMC) and regional body bone mineral content were measured in 38 women treated with GnRH agonists for 6 months for endometriosis or leiomyomata. Article Title: The auxin transport inhibitor 2,3,5-triiodobenzoic acid (TIBA) inhibits the stimulation of in vitro lateral root formation and the colonization of the tap-root cortex of Norway spruce (Picea abies) seedlings by the ectomycorrhizal fungus Laccaria bicolor. Article Snippet: The Software:Article Title: Prophylaxis of osteoporosis with calcium, estrogens and/or eelcatonin: comparative longitudinal study of bone mass. Article Snippet: Objective: To evaluate three different therapeutic regimens for the prevention of osteoporosis in natural and surgical postmenopausal women who had been found to have rapid bone loss in analytical studies.. Methods: A total of 104 naturally or surgically postmenopausal women were studied, and subsequently followed-up during 1 year for avoidance of the influence of seasonal variation on bone mass, a factor overlooked in several studies.. They were randomized into four groups of 26 patients each: the untreated control group (mean age 50 + 5 years); the hormonal replacement treatment (HRT) group (mean age 48 + 6 years), which was treated for 24 days each month with transdermal 17/I-estradiol, 50 mg/day, together with medroxiprogesterone, 10 mg during 12 days; the calcium group (mean age 50 _+ 4 years), which was treated with elemental calcium, 1 g/day; and the calcitonin group (mean age 50 _+ 5 years), which was treated for 10 days each month with eel calcitonin, 40 IU/day and with elemental calcium, 500 mg/day. Article Title: Antisense galectin-3 alters thymidine incorporation in human MDA-MB435 breast cancer cells Article Snippet: Galectin-3 is a 30-kDa galactose-binding protein member of the galectin family.. Galectin-3 is involved in multiple intracellular and extracellular biological functions, e.g. interactions with laminin and with nucleic acids.. This latter property is consistent with the presence of a serumresponse factor-like domain at the amino-terminal part of the protein. Article Title: Evidence that the loss of bone mass induced by GnRH agonists is not totally recovered. Article Snippet: There is disagreement as to whether the loss of bone mass induced by GnRH agonists is reversible.. In part, the differences of opinion might be attributed to the fact that the influence of weight and seasonal changes on bone mass is often overlooked.. Taking into consideration weight and seasonal changes in bone mass, total (TBBMC) and regional body bone mineral content were measured in 38 women treated with GnRH agonists for 6 months for endometriosis or leiomyomata. Article Title: The auxin transport inhibitor 2,3,5-triiodobenzoic acid (TIBA) inhibits the stimulation of in vitro lateral root formation and the colonization of the tap-root cortex of Norway spruce (Picea abies) seedlings by the ectomycorrhizal fungus Laccaria bicolor. Article Snippet: The |